Enfermedades inflamatorias y neoplásicas del tracto gastrointestinal, enfermedades hepáticas prevalentes
ENGASTRO
Universitat de València
Valencia, EspañaPublications in collaboration with researchers from Universitat de València (7)
2024
-
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Alimentary Pharmacology and Therapeutics
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics
2023
-
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction
Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162
2021
-
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
American Journal of Gastroenterology, Vol. 116, Núm. 11, pp. 2250-2257
2019
-
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 42, Núm. 9, pp. 579-592
2015
-
High efficacy and safety of triple therapy in hcv genotype 1 and moderate fibrosis: A multicenter study of clinical practice in Spain
Annals of Hepatology, Vol. 14, Núm. 4, pp. 477-486
1999
-
Synthesis of nitric oxide in the dorsal motor nucleus of the vagus mediates the inhibition of gastric acid secretion by central bombesin
British Journal of Pharmacology, Vol. 127, Núm. 7, pp. 1603-1610